null
ChEBI ID: 16733
| Member | Definition | Role |
|---|---|---|
| alpha-aminobutyric acid | An optically active form of alpha-aminobutyric acid having D-configuration. | D-alpha-aminobutyric acid |
| alpha-methylmethionine | alpha-methylmethionine | |
| copper histidine | An optically active form of histidine having D-configuration. | D-histidine zwitterion; D-histidine |
| D-alanine | The D-enantiomer of alanine. | D-alanine zwitterion; D-alanine |
| d-aspartic acid | The D-enantiomer of aspartic acid. | D-aspartic acid |
| d-glutamate | An optically active form of glutamic acid having D-configuration. | D-glutamic acid |
| d-glutamine | The D-enantiomer of glutamine. | D-glutamine zwitterion; D-glutamine |
| D-leucine | The D-enantiomer of leucine. | D-leucine zwitterion; D-leucine |
| D-proline | The D-enantiomer of proline. | D-proline zwitterion; D-proline |
| D-serine | The R-enantiomer of serine. | D-serine zwitterion; D-serine |
| D-tryptophan | The D-enantiomer of tryptophan. | D-tryptophan zwitterion; D-tryptophan |
| D-tyrosine | An optically active form of tyrosine having D-configuration. | D-tyrosine zwitterion; D-tyrosine |
| D-valine | The D-enantiomer of valine. | D-valine zwitterion; D-valine |
| n-methylaspartate | An aspartic acid derivative having an N-methyl substituent and D-configuration. | N-methyl-D-aspartic acid |
| phenylalanine | The D-enantiomer of phenylalanine. | D-phenylalanine zwitterion; D-phenylalanine |
| tauropine | A derivative of L-alanine having a 2-sulfoethyl group attached to the alpha-nitrogen. | tauropine |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 882 (8.27) | 18.7374 |
| 1990's | 4,181 (39.21) | 18.2507 |
| 2000's | 3,192 (29.94) | 29.6817 |
| 2010's | 1,919 (18.00) | 24.3611 |
| 2020's | 488 (4.58) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 65 (0.58%) | 5.53% |
| Reviews | 442 (3.97%) | 6.00% |
| Case Studies | 38 (0.34%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10,583 (95.10%) | 84.16% |